Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Net Margin: 2016-2025

Historic Net Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to 15.05%.

  • Collegium Pharmaceutical's Net Margin rose 919.00% to 15.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.72%, marking a year-over-year decrease of 706.00%. This contributed to the annual value of 6.71% for FY2024, which is 141.00% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Net Margin stood at 15.05% for Q3 2025, which was up 136.10% from 6.37% recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Net Margin high stood at 89.23% for Q2 2021, and its period low was -91.49% during Q4 2021.
  • For the 3-year period, Collegium Pharmaceutical's Net Margin averaged around 9.28%, with its median value being 9.60% (2023).
  • In the last 5 years, Collegium Pharmaceutical's Net Margin tumbled by 10,061bps in 2021 and then soared by 8,594bps in 2022.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Net Margin stood at -91.49% in 2021, then soared by 8,594bps to -5.55% in 2022, then skyrocketed by 2,688bps to 21.33% in 2023, then tumbled by 1,444bps to 6.89% in 2024, then soared by 919bps to 15.05% in 2025.
  • Its Net Margin stands at 15.05% for Q3 2025, versus 6.37% for Q2 2025 and 1.36% for Q1 2025.